Immunology of scabies and translational outcomes: Identifying the missing links

Current Opinion in Infectious Diseases

Volumn 26, Issue 2, 2013, Pages 116-122

  Walton, Shelley F ^a   Oprescu, Florin I ^a  

^a UNIVERSITY OF THE SUNSHINE COAST   (Australia)

Author keywords

Diagnostics; Host immune responses; Parasite evasion mechanisms; Scabies; Translational outcomes; Vaccines

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA;

BASOPHIL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; EOSINOPHIL; HOST PARASITE INTERACTION; HOST SUSCEPTIBILITY; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNITY; MAST CELL; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SCABIES; TH1 CELL; TH17 CELL; TH2 CELL; TRANSLATIONAL RESEARCH;

ADAPTIVE IMMUNITY; CYTOKINES; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; SCABIES; SKIN; T-LYMPHOCYTES; VACCINES;

EID: 84874933667     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32835eb8a6     Document Type: Review

References (43)

1. Clucas DB, Carville KS, Connors C, et al. Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia. Bull World Health Organ 2008; 86:275-281. (Pubitemid 351521854)
2. Berger TG, Steinhoff M. Pruritus in elderly patients -eruptions of senescence. Semin Cutan Med Surg 2011; 30:113-117. [Review].
3. Hu J, McKoy K, Papier A, et al. Dermatology and HIV/AIDS in Africa. J Glob Infect Dis 2011; 3:275-280.
4. Sud N, Shanker V, Sharma A, et al. Mucocutaneous manifestations in 150 HIV-infected Indian patients and their relationship with CD4 lymphocyte counts. Int J STD AIDS 2009; 20:771-774.
5. Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5:685-694. (Pubitemid 41505357)
6. Worth C, Heukelbach J, Fengler G, et al. Impaired quality of life in adults and children with scabies from an impoverished community in Brazil. Int J Dermatol 2012; 51:275-282.
7. La Vincente S, Kearns T, Connors C, et al. Community management of endemic scabies in remote aboriginal communities of northern Australia: low treatment uptake and high ongoing acquisition. PLoS Negl Trop Dis 2009; 3:e444.
8. Walton SF. The immunology of susceptibility and resistance to scabies. Parasite Immunol 2010; 32:532-540.
9. Roberts LJ, Huffam SE, Walton SF, et al. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect 2005; 50:375-381. (Pubitemid 40692020)
10. Walton SF, Pizzutto S, Slender A, et al. Increased allergic immune response to Sarcoptes scabiei antigens in crusted versus ordinary scabies. Clin Vaccine Immunol 2010; 17:1428-1438.
11. Crivellato E, Travan L, Ribatti D. Mast cells and basophils: a potential link in promoting angiogenesis during allergic inflammation. Int Arch Allergy Immunol 2010; 151:89-97.
12. Walton SF, Beroukas D, Roberts-Thomson P, et al. New insights into disease pathogenesis in crusted (Norwegian) scabies: the skin immune response in crusted scabies. Br J Dermatol 2008; 158:1247-1255. (Pubitemid 351692869)
13. Legrand F, Woerly G, Driss V, et al. Innate immune function of eosinophils: from antiparasite to antitumor cells. Methods Mol Biol 2008; 415:215-240.
14. Jacobsen EA, Zellner KR, Colbert D, et al. Eosinophils regulate dendritic cells and Th2 pulmonary immune responses following allergen provocation. J Immunol 2011; 187:6059-6068.
15. Jacobsen EA, Taranova AG, Lee NA, et al. Eosinophils: singularly destructive effector cells or purveyors of immunoregulation? J Allergy Clin Immunol 2007; 119:1313-1320. (Pubitemid 46855871)
16. Amer M, Mostafa FF, Nasr AN, et al. The role of mast cells in treatment of scabies. Int J Dermatol 1995; 34:186-189.
17. Ito Y, Satoh T, Takayama K, et al. Basophil recruitment and activation in inflammatory skin diseases. Allergy 2011; 66:1107-1113.
18. Akdis M, Palomares O, van de Veen W, et al. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. J Allergy Clin Immunol 2012; 129:1438-1449.
19. Lalli PN, Morgan MS, Arlian LG. Skewed Th1/Th2 immune response to Sarcoptes scabiei. J Parasitol 2004; 90:711-714. (Pubitemid 39128722)
20. Wang CH, Lee SC, Huang SS, et al. Risk factors for scabies in Taiwan. J Microbiol Immunol Infect 2012; 45:276-280.
21. Walton SF, McBroom J, Mathews JD, et al. Crusted scabies: a molecular analysis of Sarcoptes scabiei variety hominis populations from patients with repeated infestations. Clin Infect Dis 1999; 29:1226-1230. (Pubitemid 30265643)
22. Segre JA. Epidermal barrier formation and recovery in skin disorders. J Clin Invest 2006; 116:1150-1158.
23. Sawa M, Tsukamoto T, Kiyoi T, et al. New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs. J Med Chem 2002; 45:930-936. (Pubitemid 34173944)
24. Burkhart CG. Recent immunologic considerations regarding the itch and treatment of scabies. Dermatol Online J 2006; 12:7.
25. Mika A, Goh P, Holt DC, et al. Scabies mite peritrophins are potential targets of human host innate immunity. PLoS Negl Trop Dis 2011; 5:e1331.
26. Mika A, Reynolds SL, Mohlin FC, et al. Novel scabies mite serpins inhibit the three pathways of the human complement system. PLoS One 2012; 7:e40489.
27. Mika A, Reynolds SL, Pickering D, et al. Complement inhibitors from scabies mites promote streptococcal growth -a novel mechanism in infected epidermis? PLoS Negl Trop Dis 2012; 6:e1563.
28. Bergstrom FC, Reynolds S, Johnstone M, et al. Scabies mite inactivated serine protease paralogs inhibit the human complement system. J Immunol 2009; 182:7809-7817.
29. Arlian LG, Fall N, Morgan MS. In vivo evidence that Sarcoptes scabiei (Acari: Sarcoptidae) is the source of molecules that modulate splenic gene expression. J Med Entomol 2007; 44:1054-1063. (Pubitemid 350208239)
30. Arlian LG, Morgan MS, Neal JS. Modulation of cytokine expression in human keratinocytes and fibroblasts by extracts of scabies mites. Am J Trop Med Hyg 2003; 69:652-656. (Pubitemid 38248239)
31. Arlian LG, Morgan MS, Neal JS. Extracts of scabies mites (Sarcoptidae: Sarcoptes scabiei) modulate cytokine expression by human peripheral blood mononuclear cells and dendritic cells. J Med Entomol 2004; 41:69-73. (Pubitemid 38171312)
32. Arlian LG, Morgan MS, Paul CC. Evidence that scabies mites (Acari: Sarcoptidae) influence production of interleukin-10 and the function of T-regulatory cells (Tr1) in humans. J Med Entomol 2006; 43:283-287. (Pubitemid 44743538)
33. Elder BL, Arlian LG, Morgan MS. Sarcoptes scabiei (Acari: Sarcoptidae) mite extract modulates expression of cytokines and adhesion molecules by human dermal microvascular endothelial cells. J Med Entomol 2006; 43:910-915. (Pubitemid 44734890)
34. Morgan MS, Arlian LG. Response of human skin equivalents to Sarcoptes scabiei. J Med Entomol 2010; 47:877-883.
35. Mullins JS, Arlian LG, Morgan MS. Extracts of Sarcoptes scabiei De Geer downmodulate secretion of IL-8 by skin keratinocytes and fibroblasts and of GM-CSF by fibroblasts in the presence of proinflammatory cytokines. J Med Entomol 2009; 46:845-851.
36. Linhart B, Valenta R. Vaccines for allergy. Curr Opin Immunol 2012; 24:354-360.
37. Holt DC, Burgess ST, Reynolds SL, et al. Intestinal proteases of free-living and parasitic astigmatid mites. Cell Tissue Res 2012. [Epub ahead of print].
38. Dupuy A, Dehen L, Bourrat E, et al. Accuracy of standard dermoscopy for diagnosing scabies. J Am Acad Dermatol 2007; 56:53-62. (Pubitemid 44969301)
39. Jayaraj R, Hales B, Viberg L, et al. A diagnostic test for scabies: IgE specificity for a recombinant allergen of Sarcoptes scabiei. Diagn Microbiol Infect Dis 2011; 71:403-407.
40. Walton SF, Currie BJ. Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev 2007; 20:268-279. (Pubitemid 46709305)
41. Alasaad S, Walton S, Rossi L, et al. Sarcoptes-World Molecular Network (Sarcoptes-WMN): integrating research on scabies. Int J Infect Dis 2011; 15:e294-e297.
42. Worth C, Heukelbach J, Fengler G, et al. Acute morbidity associated with scabies and other ectoparasitoses rapidly improves after treatment with ivermectin. Pediatr Dermatol 2012; 29:430-436.
43. Jin-gang A, Sheng-xiang X, Sheng-bin X, et al. Quality of life of patients with scabies. J Eur Acad Dermatol Venereol 2010; 24:1187-1191.